{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:31:28Z","timestamp":1794108688663,"version":"4.8.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KY232"],"award-info":[{"award-number":["2022KY232"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY21H280002"],"award-info":[{"award-number":["LY21H280002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.yexcr.2025.114726","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:14:36Z","timestamp":1756221276000},"page":"114726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cryptotanshinone instigates ferroptosis to inhibit the development of tamoxifen-resistant breast cancer via the AMPK induced BECN1-SLC7A11 complex axis"],"prefix":"10.1016","volume":"451","author":[{"given":"Mengning","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aini","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7187-2514","authenticated-orcid":false,"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114726_bib1","article-title":"Breast cancer, cold spring harb","volume":"14","author":"Visvader","year":"2024","journal-title":"Perspect. Med."},{"key":"10.1016\/j.yexcr.2025.114726_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103674","article-title":"Breast cancer highlights from 2023: knowledge to guide practice and future research","volume":"74","author":"Cardoso","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.yexcr.2025.114726_bib3","article-title":"Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER+) breast cancer","volume":"1879","author":"Toska","year":"2024","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer"},{"key":"10.1016\/j.yexcr.2025.114726_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pharmthera.2013.05.005","article-title":"Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs","volume":"139","author":"Yang","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2025.114726_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41416-023-02158-5","article-title":"Tamoxifen evolution","volume":"128","author":"Howell","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2025.114726_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/1040-8428(93)90008-R","article-title":"Tamoxifen resistance in breast cancer","volume":"14","author":"Wiebe","year":"1993","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.yexcr.2025.114726_bib7","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2165\/00003495-200161120-00004","article-title":"Tamoxifen resistance in breast cancer","volume":"61","author":"Dorssers","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.yexcr.2025.114726_bib8","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1021\/acs.jmedchem.3c00136","article-title":"Targeting the estrogen receptor for the treatment of breast cancer: recent advances and challenges","volume":"66","author":"Rej","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yexcr.2025.114726_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121110","article-title":"Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy","volume":"277","author":"Niu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.yexcr.2025.114726_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114726_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2025.114726_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102952","article-title":"RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer","volume":"68","author":"Xu","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexcr.2025.114726_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41419-022-04579-1","article-title":"Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114726_bib14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41419-024-06814-3","article-title":"Targeting LINC00152 activates cAMP\/Ca2+\/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer","volume":"15","author":"Saatci","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114726_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40880-018-0288-x","article-title":"Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer","volume":"38","author":"Koppula","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.yexcr.2025.114726_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.yexcr.2025.114726_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102317","article-title":"Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer","volume":"52","author":"Ouyang","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexcr.2025.114726_bib18","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.ymthe.2020.08.021","article-title":"xCT: a critical molecule that links cancer metabolism to redox signaling","volume":"28","author":"Liu","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2025.114726_bib19","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","article-title":"AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system Xc\u2013 activity","volume":"28","author":"Song","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.yexcr.2025.114726_bib20","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1080\/15548627.2018.1513758","article-title":"BECN1 is a new driver of ferroptosis","volume":"14","author":"Kang","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.yexcr.2025.114726_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2020.104633","article-title":"Cryptotanshinone: a review of its pharmacology activities and molecular mechanisms","volume":"145","author":"Wu","year":"2020","journal-title":"Fitoterapia"},{"key":"10.1016\/j.yexcr.2025.114726_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ptr.6815","article-title":"Recent advances and future directions in anti\u2010tumor activity of cryptotanshinone: a mechanistic review","volume":"35","author":"Ashrafizadeh","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.yexcr.2025.114726_bib23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.apsb.2021.09.014","article-title":"c-MYC-mediated TRIB3\/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2","volume":"12","author":"Su","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.yexcr.2025.114726_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114940","article-title":"Myricetin inhibits interferon-\u03b3-induced PD-L1 and IDO1 expression in lung cancer cells","volume":"197","author":"Chen","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114726_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","article-title":"Metformin induces ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer","volume":"40","author":"Yang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114726_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","article-title":"TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11\/xCT K11-linked ubiquitination and degradation","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2025.114726_bib27","doi-asserted-by":"crossref","unstructured":"D.G. Hardie, Minireview: the AMP-activated protein kinase Cascade: the key sensor of cellular energy status, (n.d.). https:\/\/dx.doi.org\/10.1210\/en.2003-0982 (accessed August 13, 2025).","DOI":"10.1210\/en.2003-0982"},{"key":"10.1016\/j.yexcr.2025.114726_bib28","article-title":"Preparation and optimization of surface stabilized cryptotanshinone nanocrystals with enhanced bioavailability","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114726_bib29","doi-asserted-by":"crossref","unstructured":"Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics, (n.d.). https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2055 (accessed August 8, 2025).","DOI":"10.3390\/biomedicines10092055"},{"key":"10.1016\/j.yexcr.2025.114726_bib30","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1021\/acsnano.2c10893","article-title":"Oxygen self-generating nanoreactor mediated ferroptosis activation and immunotherapy in triple-negative breast cancer","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.yexcr.2025.114726_bib31","first-page":"121","article-title":"Recent insights into the biological activities and drug delivery systems of tanshinones","volume":"11","author":"Cai","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.yexcr.2025.114726_bib32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/pharmaceutics14061131","article-title":"Strategies and mechanism in reversing intestinal drug efflux in oral drug delivery","volume":"14","author":"Lu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.yexcr.2025.114726_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yexcr.2025.114726_bib34","unstructured":"S. Ghosh, T. Roy, Nanoparticulate drug-delivery Systems: Lymphatic Uptake and its Gastrointestinal Applications, (n.d.)."},{"key":"10.1016\/j.yexcr.2025.114726_bib35","first-page":"96","article-title":"Liposomal formulations for enhanced lymphatic drug delivery","volume":"8","author":"Kim","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.yexcr.2025.114726_bib36","series-title":"Enhancement in Drug Delivery","year":"2007"},{"key":"10.1016\/j.yexcr.2025.114726_bib37","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1080\/00365521.2021.1961306","article-title":"Perfluoroalkyl substances are increased in patients with late-onset ulcerative colitis and induce intestinal barrier defects ex vivo in murine intestinal tissue","volume":"56","author":"Fart","year":"2021","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.yexcr.2025.114726_bib38","article-title":"Berberine alleviates fructose-induced hepatic injury via ADK\/AMPK\/Nrf2 pathway: a novel insight","volume":"179","author":"Cheng","year":"2024","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.yexcr.2025.114726_bib39","unstructured":"Resveratrol stimulates AMP kinase activity in neurons - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/17438283\/(accessed August 13, 2025)."},{"key":"10.1016\/j.yexcr.2025.114726_bib40","doi-asserted-by":"crossref","DOI":"10.3945\/ajcn.110.001925","article-title":"Sensing of energy and nutrients by AMP-activated protein kinase","volume":"93","author":"Hardie","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.yexcr.2025.114726_bib41","article-title":"A review of the biological activity and pharmacology of cryptotanshinone, an important active constituent in Danshen","volume":"137","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.yexcr.2025.114726_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/ijms21010265","article-title":"Cryptotanshinone from the Salvia miltiorrhiza bunge attenuates ethanol-induced liver injury by activation of AMPK\/SIRT1 and Nrf2 signaling pathways","volume":"21","author":"Nagappan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114726_bib43","article-title":"An integrative strategy for discovery of functional compound combination from Traditional Chinese medicine: Danhong injection as a model","volume":"138","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.yexcr.2025.114726_bib44","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to iron out cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2025.114726_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115592","article-title":"SIRT3-mediated autophagy contributes to ferroptosis-induced anticancer by inducing the formation of BECN1-SLC7A11 complex","volume":"213","author":"Huang","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114726_bib46","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2025.114726_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103304","article-title":"SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by CDK4\/6 inhibitors","volume":"76","author":"Cui","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexcr.2025.114726_bib48","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1073\/pnas.1220895110","article-title":"RAC1P29S is a spontaneously activating cancer-associated GTPase","volume":"110","author":"Davis","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.yexcr.2025.114726_bib49","article-title":"System Xc\u2212\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114726_bib50","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/pro.2984","article-title":"Conformational flexibility of BECN1: essential to its key role in autophagy and beyond","volume":"25","author":"Mei","year":"2016","journal-title":"Protein Sci."},{"key":"10.1016\/j.yexcr.2025.114726_bib51","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41419-020-2467-3","article-title":"The autophagy-independent role of BECN1 in colorectal cancer metastasis through regulating STAT3 signaling pathway activation","volume":"11","author":"Hu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114726_bib52","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/15548627.2015.1029836","article-title":"A novel autophagy-independent, oncosuppressive function of BECN1: Degradation of MCL1","volume":"11","author":"Elgendy","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.yexcr.2025.114726_bib53","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","article-title":"AMPK: restoring metabolic homeostasis over space and time","volume":"81","author":"Trefts","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yexcr.2025.114726_bib54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2021.04.006","article-title":"AMPK signaling and its targeting in cancer progression and treatment","volume":"85","author":"Hsu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2025.114726_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1914786117","article-title":"Transcriptional suppression of AMPK\u03b11 promotes breast cancer metastasis upon oncogene activation","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2025.114726_bib56","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1158\/0008-5472.CAN-15-2197","article-title":"AMPK activation and metabolic reprogramming by Tamoxifen through Estrogen receptor-independent mechanisms suggests new uses for this therapeutic modality in cancer treatment","volume":"76","author":"Daurio","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114726_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/45257","article-title":"Induction of autophagy and inhibition of tumorigenesis by beclin 1","author":"Liang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2025.114726_bib58","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1080\/15548627.2016.1185576","article-title":"AMPK regulates autophagy by phosphorylating BECN1 at threonine 388","volume":"12","author":"Zhang","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.yexcr.2025.114726_bib59","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","article-title":"AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking System Xc\u2212 activity","volume":"28","author":"Song","year":"2018","journal-title":"Curr. Biol. CB"},{"key":"10.1016\/j.yexcr.2025.114726_bib60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.canlet.2017.12.025","article-title":"Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis","volume":"416","author":"Chang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2025.114726_bib61","article-title":"Mechanism of ferroptosis resistance in cancer cells, cancer drug resist","volume":"7","author":"Y","year":"2024","journal-title":"Alhambra Calif"},{"key":"10.1016\/j.yexcr.2025.114726_bib62","article-title":"AZD1775 synergizes with SLC7A11 inhibition to promote ferroptosis","volume":"68","author":"C","year":"2025","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.yexcr.2025.114726_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5650\/jos.ess24123","article-title":"Effect of cholic acid salt and its mixed micelles on the morphology of giant unilamellar vesicles (GUV)","volume":"74","author":"Miyake","year":"2025","journal-title":"J. Oleo Sci."},{"key":"10.1016\/j.yexcr.2025.114726_bib64","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2025.114726_bib65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41523-024-00685-9","article-title":"Efficacy of FERscore in predicting sensitivity to ferroptosis inducers in breast cancer","volume":"10","author":"Hu","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.yexcr.2025.114726_bib66","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad159","article-title":"Unraveling vulnerabilities in endocrine therapy-resistant HER2+\/ER+ breast cancer","volume":"164","author":"Bahnassy","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2025.114726_bib67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/1061186X.2024.2399181","article-title":"Ferroptosis-targeting drugs in breast cancer","volume":"33","author":"Zhang","year":"2025","journal-title":"J. Drug Target."},{"key":"10.1016\/j.yexcr.2025.114726_bib68","doi-asserted-by":"crossref","unstructured":"Y. Hua, N. Duan, C. Sun, F. Yang, M. Tian, Y. Sun, S. Zhao, J. Gong, Q. Liu, X. Huang, Y. Liang, Z. Fu, W. Li, Y. Yin, Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab-resistant HER2-positive breast cancer, eLife 14 (n.d.) RP103953. https:\/\/doi.org\/10.7554\/eLife.103953.","DOI":"10.7554\/eLife.103953"},{"key":"10.1016\/j.yexcr.2025.114726_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008604","article-title":"Co-Inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis","volume":"5","author":"Crawford","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2025.114726_bib70","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41419-025-07354-0","article-title":"Targeting estrogen-regulated system xc\u2212 promotes ferroptosis and endocrine sensitivity of ER+ breast cancer","volume":"16","author":"Cao","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114726_bib71","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12935-019-0826-x","article-title":"Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers","volume":"19","author":"Maiti","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexcr.2025.114726_bib72","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-09-2572","article-title":"Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status","volume":"70","author":"Ostrander","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114726_bib73","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/s43587-024-00769-y","article-title":"Hallmarks of female reproductive aging in physiologic aging mice","volume":"4","author":"Balough","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.yexcr.2025.114726_bib74","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5483\/BMBRep.2011.44.7.423","article-title":"Dual roles of estrogen metabolism in mammary carcinogenesis","volume":"44","author":"Chang","year":"2011","journal-title":"BMB Rep."},{"key":"10.1016\/j.yexcr.2025.114726_bib75","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.bcp.2009.05.034","article-title":"Ovariectomy and estrogen treatment modulate iron metabolism in rat adipose tissue","volume":"78","author":"Mattace Raso","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114726_bib76","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.2147\/IJN.S502104","article-title":"Harnessing the power of traditional Chinese medicine in cancer treatment: the role of nanocarriers","volume":"20","author":"Fu","year":"2025","journal-title":"Int. J. Nanomedicine"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448272500326X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448272500326X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:16:32Z","timestamp":1772817392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448272500326X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S001448272500326X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114726","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryptotanshinone instigates ferroptosis to inhibit the development of tamoxifen-resistant breast cancer via the AMPK induced BECN1-SLC7A11 complex axis","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114726"}}